2020 欧洲跨学科指南：皮肤侵袭性鳞状细胞癌—治疗

2020-02-26 欧洲皮肤病学论坛 Eur J Cancer. 2020 Feb 26.

为了更新皮肤侵袭性鳞状细胞癌(cSCC)的治疗、支持性护理、患者教育以及随访建议，欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)的多学科专家小组共同制定了

中文标题：

英文标题：

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.

发布机构：

欧洲皮肤病学论坛

发布日期：

2020-02-26

简要介绍：

为了更新皮肤侵袭性鳞状细胞癌(cSCC)的治疗、支持性护理、患者教育以及随访建议，欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)的多学科专家小组共同制定了皮肤侵袭性鳞状细胞癌的治疗指南。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=78ce41c0018e67ab, title=2020 欧洲跨学科指南：皮肤侵袭性鳞状细胞癌—治疗, enTitle=European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment., guiderFrom=Eur J Cancer. 2020 Feb 26., authorId=0, author=, summary=为了更新皮肤侵袭性鳞状细胞癌(cSCC)的治疗、支持性护理、患者教育以及随访建议，欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)的多学科专家小组共同制定了, cover=https://img.medsci.cn/2020311/1583941880034_2020535.jpg, journalId=0, articlesId=null, associationId=450, associationName=欧洲皮肤病学论坛, associationIntro=The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines. These include: oncology, immunology / allergology, plastic surgery, oral medicine and, increasingly rheumatology and other disciplines in which management of chronic inflammatory disease plays an important role., copyright=0, guiderPublishedTime=Wed Feb 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>为了更新皮肤侵袭性鳞状细胞癌(cSCC)的治疗、支持性护理、患者教育以及随访建议，欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)的多学科专家小组共同制定了皮肤侵袭性鳞状细胞癌的治疗指南。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=2046, tagName=鳞状细胞癌), TagDto(tagId=101662, tagName=皮肤侵袭)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2046, guiderKeyword=鳞状细胞癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2015, appHits=79, showAppHits=0, pcHits=707, showPcHits=1954, likes=1, shares=8, comments=13, approvalStatus=1, publishedTime=Thu Mar 12 00:05:56 CST 2020, publishedTimeString=2020-02-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 11 23:51:27 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 02:15:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])

下载请点击：

评论区 (11)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1012875, encodeId=243010128e5e7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78d62310432, createdName=122269eem75暂无昵称, createdTime=Mon Aug 30 15:07:00 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978193, encodeId=cde69e81933b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/f2a7f806f4634c8681bf986fe11987f2/75a10ab7b6744cf58ecd9fa30fbe5453.jpg, createdBy=f6a65410952, createdName=啦啦啦队长, createdTime=Wed Jun 30 13:12:57 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962138, encodeId=d4ee96213870, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=302b5490796, createdName=ms9000000580070810, createdTime=Sat May 01 16:19:05 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954239, encodeId=1bb795423920, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c345469766, createdName=ms5000001371909332, createdTime=Tue Apr 06 16:34:16 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915729, encodeId=0c0e915e29ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a355398176, createdName=ptwins, createdTime=Mon Jan 11 23:29:25 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
2021-08-30 122269eem75暂无昵称

挺好的

55 0
[GetPortalCommentsPageByObjectIdResponse(id=1012875, encodeId=243010128e5e7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78d62310432, createdName=122269eem75暂无昵称, createdTime=Mon Aug 30 15:07:00 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978193, encodeId=cde69e81933b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/f2a7f806f4634c8681bf986fe11987f2/75a10ab7b6744cf58ecd9fa30fbe5453.jpg, createdBy=f6a65410952, createdName=啦啦啦队长, createdTime=Wed Jun 30 13:12:57 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962138, encodeId=d4ee96213870, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=302b5490796, createdName=ms9000000580070810, createdTime=Sat May 01 16:19:05 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954239, encodeId=1bb795423920, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c345469766, createdName=ms5000001371909332, createdTime=Tue Apr 06 16:34:16 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915729, encodeId=0c0e915e29ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a355398176, createdName=ptwins, createdTime=Mon Jan 11 23:29:25 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
2021-06-30 啦啦啦队长

非常有用

44 0
[GetPortalCommentsPageByObjectIdResponse(id=1012875, encodeId=243010128e5e7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78d62310432, createdName=122269eem75暂无昵称, createdTime=Mon Aug 30 15:07:00 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978193, encodeId=cde69e81933b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/f2a7f806f4634c8681bf986fe11987f2/75a10ab7b6744cf58ecd9fa30fbe5453.jpg, createdBy=f6a65410952, createdName=啦啦啦队长, createdTime=Wed Jun 30 13:12:57 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962138, encodeId=d4ee96213870, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=302b5490796, createdName=ms9000000580070810, createdTime=Sat May 01 16:19:05 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954239, encodeId=1bb795423920, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c345469766, createdName=ms5000001371909332, createdTime=Tue Apr 06 16:34:16 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915729, encodeId=0c0e915e29ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a355398176, createdName=ptwins, createdTime=Mon Jan 11 23:29:25 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
2021-05-01 ms9000000580070810

1

62 0
[GetPortalCommentsPageByObjectIdResponse(id=1012875, encodeId=243010128e5e7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78d62310432, createdName=122269eem75暂无昵称, createdTime=Mon Aug 30 15:07:00 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978193, encodeId=cde69e81933b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/f2a7f806f4634c8681bf986fe11987f2/75a10ab7b6744cf58ecd9fa30fbe5453.jpg, createdBy=f6a65410952, createdName=啦啦啦队长, createdTime=Wed Jun 30 13:12:57 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962138, encodeId=d4ee96213870, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=302b5490796, createdName=ms9000000580070810, createdTime=Sat May 01 16:19:05 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954239, encodeId=1bb795423920, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c345469766, createdName=ms5000001371909332, createdTime=Tue Apr 06 16:34:16 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915729, encodeId=0c0e915e29ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a355398176, createdName=ptwins, createdTime=Mon Jan 11 23:29:25 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
2021-04-06 ms5000001371909332

棒

62 0
[GetPortalCommentsPageByObjectIdResponse(id=1012875, encodeId=243010128e5e7, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78d62310432, createdName=122269eem75暂无昵称, createdTime=Mon Aug 30 15:07:00 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978193, encodeId=cde69e81933b, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/f2a7f806f4634c8681bf986fe11987f2/75a10ab7b6744cf58ecd9fa30fbe5453.jpg, createdBy=f6a65410952, createdName=啦啦啦队长, createdTime=Wed Jun 30 13:12:57 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962138, encodeId=d4ee96213870, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=302b5490796, createdName=ms9000000580070810, createdTime=Sat May 01 16:19:05 CST 2021, time=2021-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954239, encodeId=1bb795423920, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c345469766, createdName=ms5000001371909332, createdTime=Tue Apr 06 16:34:16 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915729, encodeId=0c0e915e29ad, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a355398176, createdName=ptwins, createdTime=Mon Jan 11 23:29:25 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
2021-01-11 ptwins

好

71 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2020 欧洲跨学科指南：皮肤侵袭性鳞状细胞癌—治疗

相关指南

拓展阅读

科室

工具

服务